The 20 Best ALK-Positive Non-Small Cell Lung Cancer Doctors Near Me in Bronx, NY

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Henick is board certified in Internal Medicine. Dr. Henick is currently accepting new patients.

Dr. Kalnicki focuses on researching and implementing new technologies in the radiation treatment of cancer, with the aim of enhancing the dose to the tumor target while preserving normal tissues from radiation injury, potentially increasing tumor control and improving quality of life. He pioneered the use of intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), target motion management with 4-D radiation planning, stereotactic body radiation therapy (SBRT) and functional tumor imaging with PET-CT (positron emission tomography – CAT scan) fusion techniques. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies. Dr. Kalnicki is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Anal Cancer, Cervical Cancer, and Prostatectomy. Dr. Kalnicki is board certified in American Board Of Radiology, Inc..

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Haiying Cheng is an Oncologist practicing medicine in Bronx, New York. Dr. Cheng is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Rasim Gucalp’s research interests include novel therapies in lung cancer as well as supportive care in cancer patients. He is actively involved in the multidisciplinary care of patients with lung cancer and central nervous system tumors. He is a member of several Montefiore Medical Center/Albert Einstein College of Medicine committees including the institutional tumor board, faculty senate, Pharmacy and Therapeutic Committee, and COGME. Dr. Gucalp is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

Madhur Garg earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Prostate Cancer, Acoustic Neuroma, and Familial Prostate Cancer.

Byron Thomashow is a Pulmonary Medicine provider practicing medicine in New York, New York. Dr. Thomashow is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, and Emphysema.

Joshua Sonett is a Thoracic Surgeon and a Transplant Surgeon practicing medicine in New York, New York. Dr. Sonett is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Thymectomy, and Endoscopy. Dr. Sonett is board certified in Thoracic And Cardiac Surgery. Dr. Sonett is currently accepting new patients.

Dr. Ebright joined Columbia University Irving Medical Center after serving on the faculty at Boston University School of Medicine for six years. There, he was Director of the Center for Thoracic Oncology and Co-Director of the Lung CyberKnife Program. At Columbia, he sees patients for thoracic surgery and serves as Vice Chair of Surgery at Stamford Hospital, a Columbia partner site in Connecticut.He has numerous publications in peer-reviewed journals and has authored book chapters on a variety of topics related to thoracic surgery. In addition, he has been selected as a Castle Connolly Top Doctor, as identified in Boston, New York and Connecticut magazines. Dr. Ebright is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Endoscopy, and Gastrostomy. Dr. Ebright is board certified in Thoracic And Cardiac Surgery. Dr. Ebright is currently accepting new patients.

Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Salpingo-Oophorectomy. Dr. Shu is board certified in Internal Medicine and Medical Oncology. Dr. Shu is currently accepting new patients.

Dr. Mark E. Ginsburg is an associate Professor of Surgery at Columbia University Medical Center and surgical director of the Diaphragm Program and the Lung Volume Reduction program. Dr. Ginsburg received his MD from Tufts University School of Medicine in 1980, completed his General Surgery residency in 1985 and Thoracic and Cardiovascular Residency in 1987 both at the University of Rochester Medical Center. He is renown for his surgical work in patients with disorders of the Diaphragm, and is one of few surgeons in the country to perform pacing of the diaphragm. Dr. Ginsburg has lectured and published extensively on this subject, and recently addressed the 95th AATS Annual Meeting in 2015, presenting ten-year data on lung volume reduction surgery (LVRS). The results, based primarily on surgical experience in the Division of Thoracic Surgery at New York-Presbyterian/Columbia, showed durable benefits that should promote wider adoption of LVRS in patients with severe emphysema. Dr. Ginsburg has been an invited speaker and principal and co-investigator of numerous clinical trials, author of numerous publications in renown journals such as the Journal of The American College of Cardiology, Annals of Thoracic Surgery, and the Journal of Heart and Lung Transplant, among many others, including co-author of the book, Lung Volume Reduction Surgery published by Humana Press. He’s also currently on the department of surgery QA committee and is a member of numerous professional societies including, the American College of Surgeons, New York State Medical Society, New York Society of Thoracic Surgeons, the Society of Thoracic Surgeons and the International Society for Heart and Lung Transplantation. Dr. Ginsburg is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Advanced Bronchoscopy, and Thymectomy. Dr. Ginsburg is board certified in Thoracic And Cardiac Surgery. Dr. Ginsburg is currently accepting new patients.

Dr. Oommen comes to NYP from Boston, where he served as a thoracic surgery attending at Boston Medical Center and at Thoracic Surgery Associates. Dr. Oommen’s training included a joint MBA and medical degree at Howard University in 2004; general surgery residency at New York Medical College; cardiothoracic surgery residency at Montefiore-Albert Einstein College of Medicine; and minimally invasive thoracic surgery fellowship at Boston Medical Center.In addition to his professional duties, Dr. Oommen volunteers as Medical Director for the non-profit organization Love Without Reason. Dr. Oommen is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Gastrostomy. Dr. Oommen is board certified in Thoracic And Cardiac Surgery. Dr. Oommen is currently accepting new patients.

Rakesh Shah is a Radiologist and a Thoracic Surgeon practicing medicine in Manhasset, New York. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Lung Nodules, and Emphysema. Dr. Shah is board certified in American Board Of Radiology/Diagnostic Radiology.

Jason Karp is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Manhasset, New York. Dr. Karp is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Tracheobronchomalacia, Asthma in Children, Asthma, and Lung Nodules. Dr. Karp is board certified in American Board Of Internal Medicine/Pulmonary Disease.

William Bodner is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Bodner is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

My research is focused on breast cancer management, and on care delivery and support for breast cancer patients. Dr. Makower is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Byung-han Rhieu is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Rhieu is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Radiation Induced Meningioma, Meningioma, and Primitive Neuroectodermal Tumor (PNET).

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Chirag Shah is a Pulmonary Medicine provider practicing medicine in Bronx, New York. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His clinical expertise encompasses Lung Metastases, Lung Nodules, Bronchiectasis, and Pneumonia.